Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$7,011,938
in 3 filings, $6.7M under 10b5-1 plans

Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BAKER BROS. ADVISORS LP +$35.0M Director 1 filing
  2. Sibold William John −$6.2M President and CEO sold 6% of stake
  3. Kelley Shannon T −$773K General Counsel sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +2,873 $217.91 $626K 1,675,859
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +1,195 $219.24 $262K 177,801
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +15,005 $219.24 $3.3M 1,690,864
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +352 $220.65 $78K 178,153
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +4,408 $220.65 $973K 1,695,272
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +308 $221.24 $68K 178,461
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +3,857 $221.24 $853K 1,699,129
2023-12-12 Waltermire Robert E. Senior VP, Chief Pharma Dev. Option exercise +1,300 $87.92 $114K 6,967
2023-12-12 Waltermire Robert E. Senior VP, Chief Pharma Dev. Sale −500 $216.00 $108K 6,467
2023-12-12 Waltermire Robert E. Senior VP, Chief Pharma Dev. Sale −800 $219.00 $175K 5,667
2023-12-12 Waltermire Robert E. Senior VP, Chief Pharma Dev. Option exercise · Stock Option (Right to Buy) −1,300 23,700
2023-12-07 CRAVES FRED B Director Other disposition −1,510,521 0
2023-12-07 CRAVES FRED B Director Other disposition −46,073 1,261
2023-12-05 Lynch Brian Joseph SVP and General Counsel Option exercise +1,000 $87.09 $87K 16,001
2023-12-05 Lynch Brian Joseph SVP and General Counsel Sale −1,000 $227.33 $227K 15,001
2023-12-05 Lynch Brian Joseph SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,000 43,000
2023-12-04 Lynch Brian Joseph SVP and General Counsel Option exercise +800 $73.75 $59K 15,801
2023-12-04 Lynch Brian Joseph SVP and General Counsel Option exercise +1,000 $87.09 $87K 16,801
2023-12-04 Lynch Brian Joseph SVP and General Counsel Sale −800 $215.73 $173K 16,001
2023-12-04 Lynch Brian Joseph SVP and General Counsel Sale −1,000 $221.38 $221K 15,001

Page 41 of 82 · 1,629 trades